Mark K. Haynes

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of the HEG1–KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells”.

Inhibition of the HEG1–KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells

FASEB BioAdvances(2021)10.1096/fba.2020-00141

N/A

0DataRank · unranked

18 citations

Sara McCurdy, Wenqing Li, Mark K. Haynes, Preston Hale, Karol R. Francisco +10 more

A phenotypic screen for compounds that reverse cAMP-mediated suppression of T cell functions

SLAS DISCOVERY(2022)10.1016/j.slasd.2022.03.008

N/A

0DataRank · unranked

1 citations

Meghan Wyatt, Haim Bar, Mark K. Haynes, Bruce S. Edwards, Larry A. Sklar +2 more

The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture

Neuroscience Letters(2023)10.1016/j.neulet.2023.137419

N/A

0DataRank · unranked

5 citations

Shahani Noor, Melody S. Sun, Justine R Zimmerly, Andrea A Pasmay, Jóse Javier Sánchez +6 more